These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 20927292)

  • 1. Multidrug resistant acinetobacter.
    Manchanda V; Sanchaita S; Singh N
    J Glob Infect Dis; 2010 Sep; 2(3):291-304. PubMed ID: 20927292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis.
    Liu J; Shu Y; Zhu F; Feng B; Zhang Z; Liu L; Wang G
    J Glob Antimicrob Resist; 2021 Mar; 24():136-147. PubMed ID: 32889142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan drug-resistant
    Sobouti B; Mirshekar M; Fallah S; Tabaei A; Fallah Mehrabadi J; Darbandi A
    Med J Islam Repub Iran; 2020; 34():24. PubMed ID: 32551313
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant
    Fragkou PC; Poulakou G; Blizou A; Blizou M; Rapti V; Karageorgopoulos DE; Koulenti D; Papadopoulos A; Matthaiou DK; Tsiodras S
    Microorganisms; 2019 Jun; 7(6):. PubMed ID: 31159398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control and management of multidrug resistant
    Weinberg SE; Villedieu A; Bagdasarian N; Karah N; Teare L; Elamin WF
    Infect Prev Pract; 2020 Sep; 2(3):100077. PubMed ID: 34368717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.
    ; Guan X; He L; Hu B; Hu J; Huang X; Lai G; Li Y; Liu Y; Ni Y; Qiu H; Shao Z; Shi Y; Wang M; Wang R; Wu D; Xie C; Xu Y; Yang F; Yu K; Yu Y; Zhang J; Zhuo C
    Clin Microbiol Infect; 2016 Mar; 22 Suppl 1():S15-25. PubMed ID: 26627340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Vitro Assessment Of The Therapeutic Potential Of Polymyxins And Tigecycline Against Multidrugresistant Acinetobacter Isolates From Infected Wounds.
    Khurshid M; Rashid A; Husnain M; Rasool MH; Waqas U; Saeed M; Naeem M; Sohail M
    J Ayub Med Coll Abbottabad; 2020; 32(4):459-464. PubMed ID: 33225644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
    Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
    Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
    Salehi B; Goudarzi H; Nikmanesh B; Houri H; Alavi-Moghaddam M; Ghalavand Z
    J Infect Chemother; 2018 Jul; 24(7):515-523. PubMed ID: 29555392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter Infections in Neonates.
    Zarrilli R; Bagattini M; Esposito EP; Triassi M
    Curr Infect Dis Rep; 2018 Oct; 20(12):48. PubMed ID: 30306354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
    Clark NM; Zhanel GG; Lynch JP
    Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
    Karageorgopoulos DE; Kelesidis T; Kelesidis I; Falagas ME
    J Antimicrob Chemother; 2008 Jul; 62(1):45-55. PubMed ID: 18436554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
    Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
    Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.